On the 3rd week of each month, the Institute of Clinical and Translational Sciences invites inventors, scientists, and entrepreneurs to share lessons learned from taking ideas from the
On the 3rd week of each month, the Institute of Clinical and Translational Sciences invites inventors, scientists, and entrepreneurs to share lessons learned from taking ideas from the lab to the marketplace.
This month at Precision Medicine Thursdays at Venture Café, ICTS presents cutting edge biopsy techniques for cancer diagnosis and treatment. Hong Chen will discuss her development of a technique using ultrasound as part of a noninvasive system for the molecular diagnosis of brain tumors. Aadel Chaudhuri will present an innovative liquid biopsy technique for the detection of residual disease after cancer surgery.
Hong Chen, PhD
Hong Chen, PhD, joined the Washington University faculty in 2015 as an Assistant Professor of biomedical engineering in the School of Engineering & Applied Science and of radiation oncology at the School of Medicine. Dr. Chen earned her Ph.D. degree in Bioengineering from the University of Washington in 2011. After graduation, she worked as a senior fellow in the School of Medicine at the University of Washington. From 2012 to 2015, she was a postdoctoral research scientist in the Department of Biomedical Engineering at the Columbia University. Professor Chen’s research focuses on medical ultrasound. Her goal is to develop the ultrasound-based image-guided drug delivery platform for cancer therapy through combining the functions of ultrasound, integrating physical acoustics with the development of medical ultrasound devices and bridging basic and translational research. She has obtained significant training and made scientific contributions in physical acoustics, therapeutic ultrasound, and ultrasound imaging. She received the RWB Stephen’s prize at the World Congress in Ultrasonics/Ultrasonics International in 2005. She also earned the Young Investigator Award at the 2014 Focused Ultrasound International Symposium in recognition of her “outstanding research in the field of focused ultrasound”.
Aadel Chaudhuri, MD, PhD
Aadel Chaudhuri, MD, PhD, is an assistant professor in radiation oncology and a physician-scientist who treats lung cancer. Dr. Chaudhuri completed his medical degree at Stanford, PhD at Caltech, and undergraduate degrees at MIT. He completed his residency in radiation oncology at the Stanford Cancer Institute, where he did postdoctoral work under the Holman Pathway with Dr. Maximilian Diehn and Dr. Ash Alizadeh, showing that circulating tumor DNA (ctDNA) can serve as a biomarker for molecular residual disease (MRD) after curative-intent lung cancer treatment. He joined the faculty at Washington University in 2018, where he is continuing this line of research.
(Thursday) 4:00 pm - 5:00 pm
RSVPing is closed at this time.
Virtual Event Details
Event has already taken place!
Washington University School of Medicine